Monday, April 16, 2018

UPDATE 2-Shire sells cancer drugs to Servier for $2.4 bln as Takeda circles

* Oncology business had been attractive to Takeda (Adds shares, analyst reaction, CEO comment, Takeda no comment)
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)